Lynestrenol

also known as Linestrenol · Lynoestrenol · NSC-37725

today NCT02715232 · Ph 4

2017201820192020202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT02715232	Feb 2017 → Dec 2020	body integrity dysphoria	Medical University of Vienna	Unknown	No outcome recorded

Also used as a comparator or background therapy in 2 trials

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 11 trial
Phase 1	NCT00647933 Background	Jun → Dec 2000	infertility disorder	Organon and Co	Completed	No outcome recorded
Phase 41 trial
Phase 4	NCT01065220 Background	Feb 2010 → Jan 2014	—	Medical University of Vienna	Completed	No outcome recorded

Every value below carries the sentence it was read from. 4 sources stand behind the page.

Field	Value	Cited text
Known as	Lynestrenol	“Lyndiol® (50 μg ethinylestradiol + 2.5 mg lynestrenol) tablets orally once a day for 6 weeks.” NCT00647933 ↗ 2 NCT02715232 ↗ NCT01065220 ↗
Known as	Linestrenol	ChEMBL registry synonym — accepted as the source's own label CHEMBL2107431 ↗
Known as	Lynoestrenol	ChEMBL registry synonym — accepted as the source's own label CHEMBL2107431 ↗
Known as	NSC-37725	ChEMBL registry synonym — accepted as the source's own label CHEMBL2107431 ↗
Modality	Small molecule	— CHEMBL2107431 ↗
Route	Oral	“Lyndiol® (50 μg ethinylestradiol + 2.5 mg lynestrenol) tablets orally once a day for 6 weeks.” NCT00647933 ↗